BRX 0.25 (Rexulti 0.25 mg)
Generic Name: brexpiprazole
Pill with imprint BRX 0.25 is Brown, Round and has been identified as Rexulti 0.25 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd. and Lundbeck.
Rexulti is used in the treatment of major depressive disorder; schizophrenia; depression and belongs to the drug class atypical antipsychotics. Rexulti 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BRX 0.25
Rexulti
- Generic Name:
- brexpiprazole
- Imprint:
- BRX 0.25
- Strength:
- 0.25 mg
- Color:
- Brown
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Atypical antipsychotics
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Otsuka Pharmaceutical Co., Ltd. and Lundbeck
- National Drug Code (NDC):
- 59148-0035
More about Rexulti (brexpiprazole)
- Rexulti Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 164 Reviews
- Drug class: atypical antipsychotics
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
